How long to dissolve gout crystals
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at how long it takes for urate crystals (the cause of gout) to dissolve in the body. It may help if you have gout, are not on uric acid-lowering medicine, and have higher uric acid levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with gout by a doctor.
- Your uric acid level is above normal (greater than 60 mg/L).
- You are not currently taking any medication to lower uric acid.
- You do not have any severe, uncontrolled health problems like cancer, heart disease, or nerve problems.
- You are not pregnant or breastfeeding, and you have French national health insurance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with certain types of crystal deposits in joints (like gout, CPPD, or hydroxyapatite crystal disease). It uses scans such as ultrasound and a special CT-type scan called DECT to confirm and better understand what’s causing your symptoms.
This study uses ultrasound to look for hidden changes in joints and tendons in people who have gout. It may help doctors better understand what ultrasound can show in gout, but it doesn’t sound like it’s testing a new medicine.
This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.
This study looks at whether uric acid crystals in the foot (gout) are linked to hardening of the heart arteries. It involves CT scans of the heart and foot to check for deposits. If you have gout and heart risk factors, you may be able to help researchers understand this connection.
This trial tests a new medicine, PRX-115, given through a vein, to see if it lowers uric acid levels in people with gout who haven't had success with standard treatments. Some participants will also take methotrexate, and the results are compared to a placebo (a dummy infusion).
This trial tests an experimental drug, SSS11, to see if it is safe and how it affects uric acid levels in people with gout and high uric acid. You may not take other gout medicines during the study.
Hear when a new Gout trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.